Your prediction
Pros and Cons of Eagle Pharmaceuticals Inc in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Eagle Pharmaceuticals Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | - | - | - | - | - | - | - |
| Rockwell Medical Inc. | -2.130% | 6.857% | 5.451% | -57.457% | 24.390% | -49.911% | -92.573% |
| Pacira Pharmaceuticals | -0.540% | -9.722% | -8.879% | -4.412% | -9.722% | -42.647% | -66.949% |
| Twist Bioscience Corp | 0.720% | 9.442% | 31.032% | -18.939% | 24.022% | 44.157% | -75.151% |
Comments
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Show more
Ratings data for EGRX provided by MarketBeat
